UTI Selling And Marketing Expenses from 2010 to 2024

UTIAMC Stock   1,299  11.80  0.92%   
UTI Asset's Selling And Marketing Expenses is decreasing over the years with slightly volatile fluctuation. Selling And Marketing Expenses is expected to dwindle to about 168.8 M. From 2010 to 2024 UTI Asset Selling And Marketing Expenses quarterly data regression line had arithmetic mean of  253,311,800 and r-squared of  0.63. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2010-12-31
Previous Quarter
224.4 M
Current Value
168.8 M
Quarterly Volatility
77.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check UTI Asset financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UTI Asset's main balance sheet or income statement drivers, such as Depreciation And Amortization of 396.5 M, Interest Expense of 99 M or Selling General Administrative of 427.4 M, as well as many indicators such as . UTI financial statements analysis is a perfect complement when working with UTI Asset Valuation or Volatility modules.
  
This module can also supplement various UTI Asset Technical models . Check out the analysis of UTI Asset Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in UTI Stock

UTI Asset financial ratios help investors to determine whether UTI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UTI with respect to the benefits of owning UTI Asset security.